BioShares Biotechnology Products ETF (BBP)

NYSEARCA: BBP · IEX Real-Time Price · USD
+0.29 (0.70%)
At close: Jun 27, 2022 4:00 PM
0.00 (0.00%)
After-hours: Jun 27, 2022 8:00 PM EDT
Assets $14.41M
NAV $41.16
Expense Ratio 0.79%
PE Ratio n/a
Shares Out 350,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 20, 2017
1-Year Return -21.65%
Volume 2,968
Open 40.78
Previous Close 41.86
Day's Range 42.01 - 42.15
52-Week Low 34.12
52-Week High 54.83
Beta 0.92
Holdings 53
Inception Date Dec 17, 2014

About BBP

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.

Asset Class Portfolio-Multi Asset
Sector Biotech
Region North America
Issuer BioShares
Stock Exchange NYSEARCA
Ticker Symbol BBP
Index Tracked BioShares Biotechnology Products Index

Top 10 Holdings

22.91% of assets
Name Symbol Weight
Bny Mellon Cash Reserve Usd n/a 3.00%
Axsome Therapeutics AXSM 2.57%
PTC Therapeutics PTCT 2.45%
BridgeBio Pharma BBIO 2.25%
Zai Lab ZLAB 2.24%
Amicus Therapeutics FOLD 2.13%
Agios Pharmaceuticals AGIO 2.13%
Global Blood Therapeutics GBT 2.09%
BeiGene BGNE 2.03%
Immunocore Holdings IMCR 2.03%
View More Holdings


Ex-Dividend Amount Pay Date
Dec 20, 2017 $0.0723 Dec 27, 2017
Dec 21, 2015 $0.39725 Dec 29, 2015
Full Dividend History


Biotech ETFs That Outperformed Last Week

Biotech ETFs was the biggest gainer last week.

Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs

Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.


Beyond Clean Energy, 5 Sector ETFs Soaring to Record Highs

As most corners of the market rallied on the slew of positive news, a few sectors scaled new highs. We have highlighted five ETFs from different sectors that hit all-time highs in the recent trading ses...

Other symbols: ITBPRNXRTXSD

4 ETFs to Play the Hot Events of Q4

The S&P 500 posted its best third-quarter gains since 2010 with an advancement of 8.5%. The gains could continue as the October-December period is normally gainful for the market.

Other symbols: CLOUONLNPBW

Top-Performing ETFs of the Worst September Since 2011

After a superb August, September turned gloomy for Wall Street.

Other symbols: DXJSIPOTAN

5 ETFs Shining Bright Amid September Selling

The combination of lofty valuation, lack of additional fiscal stimulus package, election uncertainty and rising U.S.-China tensions weighed on investors' sentiment.


"Worst September in 18 Years"? 4 Sector ETFs Surviving Selloffs

After a superb August, September looks gloomy for Wall Street. Still,

Other symbols: BETZPBDRTM

Late-stage biotech ETFs rally Monday on virus treatment hopes

Late-stage biotech exchange-traded funds were among the day's biggest gainers Monday as investors pinned their hopes on medical responses to the novel coronavirus. The ALPS Medical Breakthroughs ETF wa...

Other symbols: SBIO

A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

Biotech ETFs Surge on a Flurry of Positive News

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.


ACADIA Pharmaceuticals Help Lift Biotech ETFs

While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS: A...

Other symbols: FBTIBBSBIO

Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.


A Spread of Top-Ranked ETFs That Crushed the Market in Q1

We are presenting a bunch of top performing ETFs of the first quarter with a solid Zacks ETF Rank #1 or 2 which are expected to outperform in the quarter ahead.